Moxpedia-CV Dry Syrup


MOXPEDIA-CV DRY SYRUP: Each 5ml of Constituted suspension contains Amoxycillin 200mg+ Clavulanic Acid 28.5mg in pack of 30ml.

MOXPEDIA-CV ES DRY SYRUP: Each 5ml of Constituted suspension contains Amoxycillin 600mg+ Clavulanic Acid 42.9mg in pack of 50ml.

MOXPEDIA-CV FORTE 457 DRY SYRUP: Each 5ml of Constituted suspension contains Amoxycillin 400mg+ Clavulanic Acid 57mg in pack of 30ml.

Formulation: Dry Syrups

Flavour: Strawberry Flavour



Amoxycillin: Antibacterial

Clavulanic Acid: Beta Lactamase Inhibitor /


Amoxycillin: Semi-synthetic Aminopenicillin

Clavulanic Acid: β-lactam related to penicillins.

Spectrum of Coverage:

Gram-positive bacteria

  • Staphylococcus aureus
  • Enterococcus faecalis
  • Staphylococcus epidermidis
  • Staphylococcus saprophyticus
  • Streptococcus pneumoniae
  • Streptococcus pyogenes
  • Viridans group Streptococcus

Gram-negative bacteria

  • Enterobacter species
  • Escherichia coli
  • Haemophilusinfluenzae
  • Klebsiella species
  • Moraxella catarrhalis
  • Eikenellacorrodens
  • Proteus mirabilis

Anaerobic Bacteria

  • Bacteroides species includingBacteroidesfragilis
  • Fusobacterium species
  • Peptostreptococcus species

Mechanism of Action:

Amoxycillin: It exhibits bactericidal action against susceptible organisms during the stage of active multiplication. It acts through the inhibition of biosynthesis of cell wall mucopeptide by acting on Penicillin Binding Proteins on Bacterial Cell Wall.

Clavulanic Acid: Itis a beta-lactamstructurally related to the penicillins,possesses the ability to inactivate some beta-lactamase enzymes commonly found inmicro-organisms resistant to penicillins and cephalosporins. It has good activityagainst the clinically important plasmid-mediated beta-lactamases frequently responsible fortransferred drug resistance.

The formulation of amoxicillin and clavulanic acid protects amoxicillin from degradation by some beta lactamase enzymes and extends the antibiotic spectrum of amoxicillinto include many bacteria normally resistant to amoxicillin.


  • Lower Respiratory Tract Infections
  • Acute Bacterial Otitis Media
  • Sinusitis
  • Skin and Skin Structure Infections
  • Urinary Tract Infections

Dosage & Administration:

Dosing in Patients Aged 12 weeks (3 months) and Older



Every 12 hours

 Every 8 hours

200mg/5mL OR

400mg/5mL oral suspension

125mg/5mL OR

250mg/5mL oral suspension

Otitis media, Sinusitis, Lower Respiratory Tract Infections, & more severe infections

45mg/kg/day every 12 hours

40mg/kg/day every 8 hours

Less severe infections

25mg/kg/day every 12 hours

20mg/kg/day every 8 hours

Neonates and Infants Aged <12 weeks (<3 months): 30mg/kg/day divided every 12hours, based on the amoxicillin part.


MOXPEDIA-CV DRY SYRUP is available asDry Syrup in pack of 30 ml.

MOXPEDIA-CV ES DRY SYRUP is available asDry Syrup in pack of 50 ml.

MOXPEDIA-CV FORTE 457 DRY SYRUP is available asDry Syrup in pack of 30 ml.


  1. Journal of International Medical Research,Research article First published July-August 1990
  2. Can Fam Physician. 2017 Sep; 63(9): 685–687.
  3. PediatrClin North Am. 2003 Apr; 50(2): 413–426
  4. Pediatrics (2009) 124 (1): 9–15.
  5. J Clin Med. 2019 Aug; 8(8): 1162.


There are no reviews yet.

Be the first to review “Moxpedia-CV Dry Syrup”

Your email address will not be published. Required fields are marked *

error: Content is protected !!